Skip to content
drillr.ai
Sign up

TTRX

Turn Therapeutics Inc.

NASDAQ · Healthcare · Biotechnology · US

$9.80
−2.68%
Ask drillr

Income statement

MetricTTM202520242023
Revenue
Total Revenue————
Cost of Revenue56.8K———
Gross Profit(56.8K)———
Operating Expenses
R&D Expense778.1K265.6K246.0K7.5K
SG&A Expense6.1M5.6M1.6M2.3M
General & Admin Expense—5.6M1.6M2.3M
Selling & Marketing Expense————
Other Expenses————
Total Operating Expenses6.9M5.9M1.8M2.3M
Cost and Expenses7.0M5.9M1.8M2.3M
Operating Income (EBIT)(7.0M)(5.9M)(1.8M)(2.3M)
Non-Operating
Interest Income69.0K29.6K28.7K15.9K
Interest Expense241.4K———
Net Interest Income(172.4K)29.6K28.7K15.9K
Other Non-Op Income/Expense(1.5M)2.7M28.7K15.9K
Non-Operating Income (excl Interest)(2.8M)(2.7M)(28.7K)(15.9K)
EBT (Pre-Tax Income)(8.4M)(3.2M)(1.8M)(2.3M)
Income Tax Expense————
Bottom Line
Net Income(8.4M)(3.2M)(1.8M)(2.3M)
Earnings from Cont. Ops(8.4M)(3.2M)(1.8M)(2.3M)
Earnings from Discont. Ops————
Bottom Line Net Income(8.4M)(3.2M)(1.8M)(2.3M)
Per Share
Basic EPS($0.29)($0.23)($0.13)($0.17)
Diluted EPS($0.29)($0.23)($0.13)($0.17)
Revenue Per Share$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding29.8M13.7M13.4M13.2M
Diluted Shares Outstanding29.8M13.7M13.4M13.2M
Profitability Metrics
EBITDA(4.2M)(3.1M)(1.7M)(2.2M)
D&A56.8K52.7K47.5K43.9K
EBIT(4.2M)(3.2M)(1.8M)(2.3M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026